| Chairman |
|
Tian Guanghui |
| Business Nature |
| 醫療保健 (Health Care) |
| Board Members |
Chairman, Chief Executive Officer & General Manager: Tian Guanghui
Executive Director: Hu Tianwen
Non-executive Director: Liu Haoxuan
Independent Non-executive Director: Ju Dianwen, Cao Xinwen, Xu Hong Xi.
|
| Principle Business |
|
The Group is principally engaged in dedicated to meeting clinical needs in the treatment of neuropsychiatric, infectious and andrological diseases. |
| Major Shareholders |
| Shen Jingshan & Family | 84,733,588 | NON-H SHS | 50.56% | 83.96% | 2025/11/06 | | Tian Guanghui | 8,589,967 | H Sh | 5.13% | 12.88% | 2025/11/06 | | Suzhou Hesheng Enterprise Management Consulting Partnership Enterprise | 6,783,348 | H Sh | 4.05% | 10.17% | 2025/11/06 | | Tian Guanghui | 5,726,644 | NON-H SHS | 3.42% | 5.67% | 2025/11/06 | | Jin Qing | 5,517,145 | H Sh | 3.29% | 8.27% | 2025/11/06 | | Suzhou Xieyao Private Fund Management Co., Ltd. | 5,402,703 | H Sh | 3.22% | 8.10% | 2025/11/06 | | Gongqingcheng Zhongcai Qihu Financial Control Phase II Internet Industry Inv | 4,370,157 | H Sh | 2.61% | 6.55% | 2025/11/06 |
|
|
|
|
|